SUSQUEHANNA INTERNATIONAL GROUP, LLP - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 74 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2022$23,015
-54.9%
208,506
-31.6%
0.00%
Q3 2022$51,000
-42.7%
304,975
-15.1%
0.00%
Q2 2022$89,000
-82.9%
359,276
-63.3%
0.00%
Q1 2022$520,000
-73.3%
979,594
-68.9%
0.00%
Q4 2021$1,944,000
+38.8%
3,152,832
+129.6%
0.00%
Q3 2021$1,401,000
-38.0%
1,373,157
+11.2%
0.00%
Q2 2021$2,261,000
-51.4%
1,235,148
-47.8%
0.00%
Q1 2021$4,657,000
+43.6%
2,363,941
-8.8%
0.00%
Q4 2020$3,242,000
-46.0%
2,592,938
-22.3%
0.00%
Q3 2020$6,007,000
-48.7%
3,337,183
+139.2%
0.00%
-100.0%
Q2 2020$11,703,000
+140.1%
1,394,939
+50.0%
0.00%
+200.0%
Q1 2020$4,874,000
+85.3%
930,129
+93.0%
0.00%0.0%
Q4 2019$2,631,000
+155.2%
481,934
+127.6%
0.00%
Q3 2019$1,031,000
-90.1%
211,715
-85.9%
0.00%
-100.0%
Q2 2019$10,388,000
+169.6%
1,498,916
+170.4%
0.00%0.0%
Q1 2019$3,853,000
+567.8%
554,433
+461.5%
0.00%
Q4 2018$577,000
-68.9%
98,736
-59.9%
0.00%
Q3 2018$1,858,000
+100.4%
246,012
+34.0%
0.00%
Q2 2018$927,000
-51.4%
183,556
-41.3%
0.00%
Q1 2018$1,908,000
+14.5%
312,792
+33.3%
0.00%
Q4 2017$1,666,000
+103.9%
234,656
+105.5%
0.00%
Q3 2017$817,000
+48.3%
114,200
+30.5%
0.00%
Q2 2017$551,000
-91.8%
87,500
-89.2%
0.00%
-100.0%
Q1 2017$6,689,000
+108.6%
810,815
+113.6%
0.00%
+50.0%
Q4 2016$3,207,000
+191.8%
379,534
+134.6%
0.00%
Q3 2016$1,099,000161,7450.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q2 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$6,307,0004.30%
ETF MANAGERS GROUP, LLC 8,103,641$10,130,0000.22%
AdvisorShares Investments LLC 271,873$340,0000.08%
Platform Technology Partners 60,000$75,0000.04%
PINNACLE ASSOCIATES LTD 942,079$1,178,0000.02%
HRT FINANCIAL LP 883,510$1,104,0000.02%
Virtu Financial LLC 153,908$192,0000.02%
Tekla Capital Management LLC 413,481$517,0000.02%
Aries Wealth Management 23,400$33,0000.02%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 56,932$71,0000.02%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders